Author

Fei Yan

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Real-world evaluation of 2023–2024 XBB.1.5 mRNA and protein-based COVID-19 vaccine reactogenicity from the randomized BEEHIVE trial

ABSTRACT The objective of this analysis was to assess reactogenicity profile differences between a protein- and mRNA-based COVID-19 vaccine in participants who had previously received ≥2 doses of an mRNA-based vaccine in a real-world, double-blinded, randomized, controlled trial. In the BEEHIVE/NCT06065176 trial (Clini...

Sarang K. Yoon, Andrew L. Phillips, Hong-Wei Zhao et al. · Human Vaccines & Immunothera... · 0 citations

Open access Jul 2026

Real-world effectiveness and safety of protein-based and mRNA COVID-19 vaccines (BEEHIVE trial).

The results suggest that both protein-based and mRNA vaccines are well-tolerated and significantly reduce the risk of symptomatic SARS-CoV-2 infections.

Sarang K. Yoon, Andrew L. Phillips, S. Battan-Wraith et al. · Vaccine · 1 citation